TMEM43 and breast cancer: Moreover, the analysis of their gene signature in LumA BC cells revealed that they reduce those genes that are overexpressed in Tam-resistant patients, thus suggesting that CGs could be effectively used for the treatment of LumA primary and metastatic tumors [4].